Filing Details

Accession Number:
0001225208-14-012015
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-05 15:24:40
Reporting Period:
2014-05-01
Filing Date:
2014-05-05
Accepted Time:
2014-05-05 14:24:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453593 Bacterin International Holdings Inc. BONE Biological Products, (No Disgnostic Substances) (2836) 205313323
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1508469 S Guy Cook 246 Painted Hills Road
Bozeman MT 59715
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-05-01 50,000 $0.71 3,240,049 No 4 S Direct
Common Stock Disposition 2014-05-02 230,000 $0.73 3,010,049 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,800,000 Indirect By Michelle Allison Cook Trust
Common Stock 1,800,000 Indirect By Steven Thomas Cook Trust
Common Stock 1,700,000 Indirect By Timothy Shane Cook Trust
Footnotes
  1. The reporting person recognizes that the transactions reported on this Form 4 are matchable under Section 16(b) of the Securities Exchange Act of 1934 in connection with the reporting person's purchase of 162,320 shares of common stock at a price of $.6426 per share on January 15, 2014. The reporting person has already paid to the issuer the profit realized in connection with the sale of 162,320 shares prior to the date of this transaction and this transaction does not result in any additional profit realized as calculated pursuant to the requirements of Section 16(b).
  2. The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $0.70 to $0.72 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The reporting person recognizes that the transactions reported on this Form 4 are matchable under Section 16(b) of the Securities Exchange Act of 1934 in connection with the reporting person's purchase of 162,320 shares of common stock at a price of $0.6426 per share on January 15, 2014. The reporting person has already paid to the issuer the profit realized with respect to the sale of 162,320 prior to the date of this transaction and will pay to the issuer the additional profit realized in connection with this transaction as calculated pursuant to the requirements of Section 16(b).
  4. The price shown is a weighted average sale price for shares sold in multiple transactions; the sale prices ranged from $0.70 to $0.75 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.